Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-29

Dendritic cells as possible determinants for bone marrow restricted t cells activation and bone loss in Estrogen depleted mice

Objective

Postmenopausal osteoporosis is a debilitating disease driven by estrogen deficiency. Bone loss is driven by an interplay of cytokines IL-7, TNFa, IL-1, IL-6, RANKL and IFNg. Activated, TNFa-producing T cells are critical for the increased osteoclast formation. The mechanism by which estrogen deficiency activate T cells is poorly understood.

A major breakthrough was recently made by the finding that an autoimmune-like response is central to the maintenance of osteoclastogenic cytokine secretion by T cells, including TNFa. Preliminary data have revealed that bone marrow dendritic cells, but not spleen dendritic cells, are dramatically activated by estrogen deficiency. Hypothesis: dendritic cells resident in the bone marrow may undergo a site-specific activation in estrogen deficiency and, in turn, lead to an enrichment of activated T cells.

Aim 1: To investigate in vivo the role of increased antigen presentation by dendritic cells in ovariectomy induced bone loss in mice. Strategy: OT-II transgenic mice bearing impaired T cell receptor are responsive only to the foreign antigen Ovalbumin and do not lose bone after ovariectomy. These mice will be injected with dendritic cells pulsed in vitro with Ovalbumin prior to ovariectomy. Physical analysis of bones and markers of T cells and dendritic cells activation will be evaluated.

Aim 2: To investigate the role of chemokines as possible determinants of the site-specific activation of dendritic cells. Strategy: systematic evaluation of the profile of expression of some key chemokines and their receptors on T cells and dendritic cells will be performed in controls and ovariectomized mice. Subsequently, immunostaining on human specimens for dendritic cells and chemokines will translate findings on human model. OSTEODEN will allow a substantial transfer of knowledge in the emerging field of 'Osteoimmunology', will establish long-term collaborations and will strengthen skills and independence of the proposer.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2002-MOBILITY-6
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

OIF - Marie Curie actions-Outgoing International Fellowships

Coordinator

ISTITUTI ORTOPEDICI RIZZOLI
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0